Hematopoietic growth factors and human acute leukemia.
The study of myelopoietic maturation arrest in acute myeloblastic leukemia (AML) has been eased by availability of the human recombinant hemopoietic growth factors, macrophage colony stimulating factor (M-CSF), granulocyte-(G-CSF), granulocyte-macrophage-(GM-CSF) and multilineage stimulating factor (IL-3). Nonphysiological expansion of the leukemic population is not due to escape from control by these factors. Proliferation in vitro of AML cells is dependent on the presence of one or several factors in most cases. The pattern of factor-dependency does not correlate with morphological criteria in individual cases, and may thus offer a new tool for classification of AML. Overproduction of undifferentiated cells is not due to abnormal expression of receptors for the stimulating factors acting at an immature level. Rather, autocrine secretion of early acting lymphokines maintains proliferation of the leukemic clone. When looking at causes of leukemic dysregulation, yet undefined inhibitors of differentiation probably are of equal importance as dysequilibrated stimulation by lymphokines.
Löwenberg
B
B
Dr. Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.
Touw
I
I
D002455:Cell Division; D003115:Colony-Stimulating Factors / Q000502:physiology; D006098:Granulocytes; D006410:Hematopoiesis; D006801:Humans; D007377:Interleukin-3 / Q000378:metabolism; D015470:Leukemia, Myeloid, Acute / Q000097:blood* / Q000503:physiopathology; D008264:Macrophages
D003115:Colony-Stimulating Factors; D007377:Interleukin-3